Yes, doctors can prescribe off-label, but this requires documented medical justification and typically involves informed consent
Key Takeaways Agonism Profile: Tirzepatide is a dual GLP-1/GIP agonist, while Retatrutide is a "triple agonist" targeting GLP-1, GIP, and Glucagon receptors
Stop immediately if: You experience signs of severe allergic reaction including throat swelling, difficulty breathing, widespread hives, or dizziness and confusion
Together, these actions allow the medication to help regulate blood sugar and promote feelings of fullness, which can ultimately contribute to weight loss
Semaglutide amplifies the action of GLP-1, suppressing hunger signals and encouraging the body to prioritize fat utilization for energy